TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 NOK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
1,080
|
1,678
|
1,566 |
| Financial expenses |
0
|
2
|
2 |
| Earnings before taxes |
-46
|
486
|
367 |
| EBITDA |
-46
|
487
|
369 |
| Total assets |
552
|
933
|
809 |
| Current assets |
437
|
933
|
809 |
| Current liabilities |
-60
|
5
|
63 |
| Equity capital |
526
|
808
|
650 |
| - share capital |
108
|
101
|
104 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
95.3%
|
86.6%
|
80.3% |
| Turnover per employee |
540
|
839
|
783 |
| Profit as a percentage of turnover |
-4.3%
|
29.0%
|
23.4% |
| Return on assets (ROA) |
-8.3%
|
52.3%
|
45.6% |
| Current ratio |
-728.3%
|
18660.0%
|
1284.1% |
| Return on equity (ROE) |
-8.7%
|
60.1%
|
56.5% |
| Change turnover |
-717
|
159
|
-175 |
| Change turnover % |
-40%
|
10%
|
-10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.